Novel Structure-Function Models for Estimating Retinal Ganglion Cell Count Using Pattern Electroretinography in Glaucoma Suspects

利用模式视网膜电图估算青光眼疑似患者视网膜神经节细胞数量的新型结构-功能模型

阅读:1

Abstract

Background/Objectives: The early detection of retinal ganglion cell (RGC) dysfunction is critical for timely intervention in glaucoma suspects (GSs). The combined structure-function index (CSFI), which uses visual field and optical coherence tomography (OCT) data to estimate RGC counts, may be of limited utility in GSs. This study evaluates whether steady-state pattern electroretinogram (ssPERG)-derived estimates better predict early structural changes in GSs. Methods: Fifty eyes from 25 glaucoma suspects underwent ssPERG and spectral-domain OCT. Estimated RGC counts (eRGCC) were calculated using three parameters: ssPERG-Magnitude (eRGCC(Mag)), ssPERG-MagnitudeD (eRGCC(MagD)), and CSFI (eRGCC(CSFI)). Linear regression and multivariable models were used to assess each model's ability to predict the average retinal nerve fiber layer thickness (AvRNFLT), average ganglion cell layer-inner plexiform layer thickness (AvGCL-IPLT), and rim area. Results: eRGCC(Mag) and eRGCC(MagD) were significantly correlated with eRGCC(CSFI). Both PERG-derived models outperformed eRGCC(CSFI) in predicting AvRNFLT and AvGCL-IPLT, with eRGCC(MagD) showing the strongest association with AvGCL-IPLT. Conversely, the rim area was best predicted by eRGCC(Mag) and eRGCC(CSFI). These findings support a linear relationship between ssPERG parameters and early RGC structural changes, while the logarithmic nature of visual field loss may limit eRGCC(CSFI)'s predictive accuracy in GSs. Conclusions: ssPERG-derived estimates, particularly eRGCC(MagD), better predict early structural changes in GSs than eRGCC(CSFI). eRGCC(MagD)'s superior performance in predicting GCL-IPLT highlights its potential utility as an early biomarker of glaucomatous damage. ssPERG-based models offer a simpler and more sensitive tool for early glaucoma risk stratification, and may provide a clinical benchmark for tracking recoverable RGC dysfunction and treatment response.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。